|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 487 articles |
 Page 1 of 7 
|
Samaritan in-licenses AD drug.(Alzheimer's disease)(Brief Article)
September 27, 2004
Schwarz Pharma Japan appointment.(Brief Article)
September 27, 2004
Positive new data for UCB's CDP-870 in RA.(Brief Article)
September 27, 2004
SPECTRUM.(Illustration)
September 27, 2004
BMS terminates insulin deal with Flamel.(Brief Article)
September 27, 2004
Isis selects antisense drug for development.(Isis Pharmaceuticals of t...
September 27, 2004
Wilex' WX-671 enters clinic.(Brief Article)
September 27, 2004
PowderMed and LICR start Phase I evaluation of cancer vaccine.(Ludwig ...
September 27, 2004
Amarin and Helm in fentanyl patch deal.(Amarin Technologies of Argenti...
September 27, 2004
Protherics appoints Joyce Emerson Cleary as VP, sales and marketing.(B...
September 27, 2004
Amgen appoints Arvind Sood VP, investor relations.(Brief Article)
September 27, 2004
Dennis Podlesak becomes CEO at Peninsular Pharma.(Peninsular Pharmaceu...
September 27, 2004
Appointments at Schering-Plough.(Stephan Farrand and Alan Kane )(Brief...
September 27, 2004
Ligand gets milestone from Pfizer.(Ligand Pharmaceuticals Inc)(Brief A...
September 27, 2004
Nuvelo extends and expands Kirin accord.(contracts)(Brief Article)
September 27, 2004
Prestwick's tetrabenazine on FDA fast-track.(Prestwick Pharmaceuticals...
September 27, 2004
Promotion at Otsuka America.(Terry Prime promotion)(Brief Article)
September 27, 2004
Integrated BioPharma in anthrax vaccine deal with US Navy.(Brief Artic...
September 27, 2004
Clinical benefits of Fabrazyme confirmed.(Brief Article)
September 27, 2004
Flamel and Tap enter licensing deal.(Brief Article)
September 27, 2004
GSK initiates Phase III trials of key drug using Flamel's Micropump.(G...
September 27, 2004
Positive Phase I data for Medicure's IV MC-1.(Brief Article)
September 27, 2004
IDM to commence US Phase II trial of Uvidem.(Immuno-Designed Molecules...
September 27, 2004
Indiana Rx-buying pool to start in January.(Brief Article)
September 27, 2004
$16.9M NIH grant for Coley Pharma.(National Institutes of Health. Nati...
September 27, 2004
Dainippon to give drug marketing a lift.(Dainippon Pharmaceutical Comp...
September 27, 2004
Roche's Pegasys effective in treating most difficult-to-treat form of ...
September 27, 2004
Aranesp OKed for extended dosing in EU.(Brief Article)
September 27, 2004
$1.2M NIH grant for Anadys for antibacterial development.(Brief Articl...
September 27, 2004
Opportunities in clinical genomics assessed.(Brief Article)
September 27, 2004
Private-sector output in China "95%+ generic".(Brief Article)
September 27, 2004
Servier will pay to avoid legal action.(Laboratoires Servier)(Brief Ar...
September 27, 2004
France's Eurofins boosts 1st-half sales 4.9%.(Eurofins Scientific S.A....
September 27, 2004
Business philosophy for Yamanouchi/Fujisawa merged firm Astellas revea...
September 27, 2004
CHMP recommends GSK's Kivexa for HIV.(European Committee for Medicinal...
September 27, 2004
Jelfa sets aside 100M zloty for purchases.(finance)(Brief Article)
September 27, 2004
Zentiva sees shares rise 12% in three months.(Brief Article)
September 27, 2004
Zydus Cadila to launch 43 generics in France.(Brief Article)
September 27, 2004
Ranbaxy aims for $2B generics sales by 2007.(Ranbaxy Laboratories)(Bri...
September 27, 2004
AustCancer targets European investors.(Australian Cancer Technology )(...
September 27, 2004
Provalis sees loss widen for full year as sales of diagnostics fall 52...
September 27, 2004
Acambis hit by order cancellation for vaccine.
September 27, 2004
French govt slammed over health cost "failure".
September 27, 2004
Irish Rx prices in August.(Brief Article)
September 27, 2004
UK NICE, US CMS plan pharma data collaboration to speed R&D.(National ...
September 27, 2004
Generics group slams Sicily over Rx charges.(Assogenerici )(Brief Arti...
September 27, 2004
Barrier and Healthpoint in Zimycan collaboration.(Brief Article)
September 27, 2004
Allergy Therapeutics receives award for its vaccine.(Brief Article)
September 27, 2004
Alfacell license MAb from NIH.(monoclonal antibody, National Institute...
September 27, 2004
Medarex' up to $510 mill deal with Pfizer.(Brief Article)
September 27, 2004
Warner Chilcott in acquisition talks.(Brief Article)
September 27, 2004
Seven Hills in Italian technology deal.(Seven Hills Venture Partners w...
September 27, 2004
USP Medicare Rx guide must be revised: PhRMA.(Pharmaceutical Research ...
September 27, 2004
GLSV makes further investment in Xantos Biomedicine.(Global Life Scien...
September 27, 2004
US seniors save $7M with Walgreens' Medicare discount card.(Walgreens ...
September 27, 2004
US Medicare discount Rx plan web site introduces price comparisons.
September 27, 2004
US health care in "crisis".(Brief Article)
September 27, 2004
Provalis sees loss widen for full year.(financial results)(Brief Artic...
September 27, 2004
Vernalis cuts first-half 2004 loss 50%.(finance)(Brief Article)
September 27, 2004
French Rx recycling probe.(Brief Article)
September 27, 2004
New gel pill could provide alternative to injections.(Brief Article)
September 27, 2004
Roche/GSK file once-a-month Bonviva in EU.(GlaxoSmithKline for Europea...
September 27, 2004
Sepracor prices $500M notes.(securities)(Brief Article)
September 27, 2004
Onyx gets milestone payment from Pfizer.(Onyx Pharmaceuticals )(Brief ...
September 27, 2004
Bionest Launches executive in residence program.(Bionest Partners )(Br...
September 27, 2004
Lilly's Alimta OKed in EU for two indications.(Brief Article)
September 27, 2004
4SC and Mutabilis in infectious disease deal.(Mutabilis)(Brief Article...
September 27, 2004
FDA fast-track for Inhibitex' Aurexis.(Food and Drug Administration)(B...
September 27, 2004
$13M US flu vaccine contract for Sanofi-Aventis.(Brief Article)
September 27, 2004
Kevin Young joins Gilead as exec VP, commercial operations.(Kevin Youn...
September 27, 2004
Guilford Pharma in $6M patent deal with Angiotech.(Angiotech Pharmaceu...
September 27, 2004
Saudi Arabia backs Bangladeshi drugs.(Brief Article)
September 27, 2004
Zambia set to start ARV production.(antiretroviral combination drug)(B...
September 27, 2004
Medarex and diaDexus expand accord.(Brief Article)
September 27, 2004
Roche's Zenapax promising for asthma.(Roche and Protein Design Labs, c...
September 27, 2004
|
1